Immuno-targeting the multifunctional CD38 using nanobody

Models, Molecular Radiology, Nuclear Medicine and Imaging Physiology Molecular biology Cytotoxicity Crystallography, X-Ray Biochemistry Antineoplastic Agents, Immunological Antibody Specificity Immunology and Microbiology 0303 health sciences Membrane Glycoproteins Stem cell Life Sciences 3. Good health Chemistry Antigen Medicine Nanobodies Epitope Multiple Myeloma Protein Binding Cell biology Therapeutic Antibodies: Development, Engineering, and Applications Immunology Cancer research Article Cell Line 03 medical and health sciences In vitro Cell Line, Tumor Biochemistry, Genetics and Molecular Biology Health Sciences Genetics Humans Protein Interaction Domains and Motifs Amino Acid Sequence Biology Lysosomal Calcium Signaling in Physiology and Pathology Immunotoxin FOS: Clinical medicine Single-Domain Antibodies ADP-ribosyl Cyclase 1 Immunotoxin Therapy for Cancer Treatment FOS: Biological sciences Protein Conformation, beta-Strand Cell culture CD34 Drug Screening Assays, Antitumor CD38
DOI: 10.1038/srep27055 Publication Date: 2016-06-02T09:28:13Z
ABSTRACT
CD38, as a cell surface antigen is highly expressed in several hematologic malignancies including multiple myeloma (MM) and has been proven to be good target for immunotherapy of the disease. CD38 also signaling enzyme responsible metabolism two novel calcium messenger molecules. To able this multifunctional protein, we generated series nanobodies against with high affinities. Crystal structures complexes were solved, identifying three separate epitopes on carboxyl domain. Chromobodies, engineered by tagging nanobody fluorescence proteins, provide fast, simple versatile tools quantifying expression. Results confirmed that was malignant MM cells compared normal white blood cells. The immunotoxin constructed splicing bacterial toxin, PE38 shows selective cytotoxicity patient-derived well lines, half maximal effective concentration reaching low 10(-11) molar. effectiveness can further increased stimulating expression using retinoid acid. These results set stage development clinical therapeutics diagnostic screening myeloma.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (56)
CITATIONS (62)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....